Close Menu

NEW YORK (GenomeWeb) – Great Basin Scientific announced today that it has completed a clinical trial and 510(k) submission to the US Food and Drug Administration for its Bordetella Direct Test for Bordetella pertussis, the infectious agent that causes whooping cough. The company is also seeking a CE mark for the test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sep
30
Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Oct
09
Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.